Objectives: To identify some biochemical parameters that help predict LV remodelling after STEMI. By determining serum levels of Resisten and IL-6 in patients with ST-segment elevation MI (STEMI) and apparently healthy controls. Patients & Methods: This prospective case-controlled study was conducted from beginning May 2023 to end of October 2023. This study was conducted on 110 individuals, including sixty-two patients (50 males and 12 females) who had undergone a STEMI and forty-eight healthy control subjects. The information about patients in this study was retrieved from patients' hospital records. The samples were collected from Azadi Teaching Hospital/ Kirkuk on patients with STEMI. Forty-eight of apparently healthy sex and age-matched controls were included in this study. The data were collected from the cases group as (G2) means: From the moment the patient arrives to internal resuscitation and up to 48 hours and at the baseline of the STEMI (ST elevation of the myocardial fraction), and (G3) means: After 4-6 months follow up, These states were also compared to the control group composed of (48) individuals who were apparently healthy. About five ml of blood was collected from the antecubital vein for both patients and healthy individuals in an anticoagulant tube to estimate the Resisten and IL-6 levels. Results: The results of the study showed that the serum level of resisten were significantly higher in group G2 (patients group) in comparison to those of the A1 (control group) P <0.01. The current research demonstrated non-significant differences in IL-6 levels between (G1 and G2), while showing highly significant differences between A1 and A3; this was also applicable for G2 and G3. Conclusion: The current study concluded that there are significantly increasing of Resistin levels in patients in matching to control groups. Also, it was noticed that IL-6 mean concentration levels were lower in A2 in comparison to A1 but higher than in A3.
Read full abstract